StonvexLoading…
StonvexStonvexStonvexCore line items from SCCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.25B | $13.42B | $9.55B | $6.17B |
Operating Income | $2.48B | $7.00B | $4.89B | $3.12B |
Net Income | $1.58B | $4.35B | $3.04B | $1.93B |
EPS (Diluted) | $1.92 | $5.24 | $3.71 | $2.39 |
Total Assets | $21.93B | $21.38B | $20.33B | $19.55B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.92B | $4.30B | $3.95B | $3.33B |
Free Cash Flow OCF − CapEx | $1.25B | $3.43B | $2.36B | $1.14B |
Shares Outstanding | 821.70M | 826.60M | 815.80M | 804.10M |